-
Product Insights
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 – Drugs In Development, 2023
Global Markets Direct’s Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 provides in depth analysis on Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 – Drugs In Development, 2023
Global Markets Direct’s Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 provides in depth analysis on Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Cell Division Cycle 7 Related Protein Kinase – Drugs In Development, 2023
Global Markets Direct’s Cell Division Cycle 7 Related Protein Kinase provides in depth analysis on Cell Division Cycle 7 Related Protein Kinase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Parathyroid Hormone/Parathyroid Hormone Related Peptide Receptor – Drugs In Development, 2023
Global Markets Direct’s Parathyroid Hormone/Parathyroid Hormone Related Peptide Receptor provides in depth analysis on Parathyroid Hormone/Parathyroid Hormone Related Peptide Receptor targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
Calcitonin Gene Related Peptide Type 1 Receptor – Drugs In Development, 2023
Global Markets Direct’s Calcitonin Gene Related Peptide Type 1 Receptor provides in depth analysis on Calcitonin Gene Related Peptide Type 1 Receptor targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Mas Related G Protein Coupled Receptor MRG – Drugs In Development, 2023
Global Markets Direct’s Mas Related G Protein Coupled Receptor MRG provides in depth analysis on Mas Related G Protein Coupled Receptor MRG targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Prolow Density Lipoprotein Receptor Related Protein 1 – Drugs In Development, 2023
Global Markets Direct’s Prolow Density Lipoprotein Receptor Related Protein 1 provides in depth analysis on Prolow Density Lipoprotein Receptor Related Protein 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Low Density Lipoprotein Receptor Related Protein 6 – Drugs In Development, 2023
Global Markets Direct’s Low Density Lipoprotein Receptor Related Protein 6 provides in depth analysis on Low Density Lipoprotein Receptor Related Protein 6 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Low Density Lipoprotein Receptor Related Protein 5 – Drugs In Development, 2023
Global Markets Direct’s Low Density Lipoprotein Receptor Related Protein 5 provides in depth analysis on Low Density Lipoprotein Receptor Related Protein 5 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pirenzepine in HIV Related Neurological Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pirenzepine in HIV Related Neurological Diseases report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pirenzepine in HIV Related Neurological Diseases Drug Details: Pirenzepine (WST-057)...